Clinical Trial: TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

---

Official Title: TRK-100STP PhaseIIb/III Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)

Brief Summary:

In Chronic Renal Failure (CRF) patients with primary glomerular disease or nephrosclerosis as the primary disease:

• To confirm the superiority of TRK-100STP over placebo
• To determine the recommended therapeutic dose in the 2 doses of TRK-100STP
• To assess the safety of TRK-100STP